Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Synergistic Anti-Proliferative Effects of Lenalidomide and Dexamethasone on the Ht-29 Cell Line Through Apoptotic Genes Publisher



Hajimirza Shafiesoltani P1 ; Forouzesh F1 ; Shabani M2 ; Aghaei M3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
  2. 2. Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3. Department of Clinical Biochemistry, School of Pharmacy & Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran

Source: International Journal of Cancer Management Published:2021


Abstract

Background: Colorectal cancer (CRC) is the third most common cancer among men and the second most common type of cancer among women worldwide. The resistance of tumor cells to apoptosis is caused by changes in the expression of anti-apoptotic or pro-apoptotic proteins. Histone deacetylase inhibitors (HDACi) are known to cause changes in gene expression. Objectives: The present study aimed at investigating the anti-proliferative effects of lenalidomide (LEN) as HDACi and dexamethasone (DEX) on the human colon cancer HT-29 cell line. Methods: The HT-29 cell line was treated with various concentrations of LEN and DEX individually and in combination for 24, 48, and 72 hours. Cytotoxicity was evaluated by MTT assay. The half-maximal inhibitory concentration (IC50) was measured, and quantitative real-time polymerase chain reaction (qRT-PCR) was also performed to examine the expression of Bcl-2, Bax, Fas, and FasL genes. Results: The combination of LEN (1000 µM) with DEX (100 µM) showed potent synergistic anti-proliferative activities in a time-and dose-dependent manner. The combination of these drugs induced cell death by affecting the extrinsic and intrinsic apoptotic gene expression profiles. Conclusions: The combination of LEN with DEX can be proposed as a new therapeutic approach for CRC. © 2021, Author(s).
Related Docs
View other Related Docs
1. Evaluation of Antitumor Effects of Aspirin and Lgk974 Drugs on Cellular Signaling Pathways, Cell Cycle and Apoptosis in Colorectal Cancer Cell Lines Compared to Oxaliplatin Drug, Fundamental and Clinical Pharmacology (2020)
2. Differential Effects of Β-Hydroxybutyrate and Α-Ketoglutarate on Hct-116 Colorectal Cancer Cell Viability Under Normoxic and Hypoxic Low-Glucose Conditions: Exploring the Role of Src, Hif1α, Acat1, and Sirt2 Genes, Molecular Genetics and Genomics (2025)
3. In Vitro Cytotoxic Evaluation of Some Synthesized Cox-2 Inhibitor Derivatives Against a Panel of Human Cancer Cell Lines, Research in Pharmaceutical Sciences (2013)
4. Tbx15 and Sdhb Expression Changes in Colorectal Cancer Serve As Potential Prognostic Biomarkers, Experimental and Molecular Pathology (2024)
5. Dihydroartemisinin Enhances the Therapeutic Efficacy of Bh3 Mimetic Inhibitor in Acute Lymphoblastic Leukemia Cells Via Inhibition of Mcl-1, Asian Pacific Journal of Cancer Prevention (2024)
6. Steroid Receptor Rna Activator Gene Footprint in the Progression and Drug Resistance of Colorectal Cancer Through Oxidative Phosphorylation Pathway, Life Sciences (2021)
7. Identification of Genes Related to Ribosomal Proteins in Colorectal Cancer: Exploring Their Potential As Biomarkers, Prognostic Indicators, and Therapeutic Targets, Molecular Biology Reports (2024)
8. Effects of Disulfiram on Apoptosis in Panc-1 Human Pancreatic Cancer Cell Line, Research in Pharmaceutical Sciences (2014)
Experts (# of related papers)
View all Related Experts
Mina Mirian (3)
Maryam Yazdi (1)
Other Related Docs
9. The Effects of Abt-199 and Dihydroartemisinin Combination on Cell Growth and Apoptosis in Human U937 and Kg-1 Cancer Cells, Asian Pacific Journal of Cancer Prevention (2024)
10. Comparison of Interleukin 18 Gene Expression and Its Serum Level Between Iranian Colorectal Cancer (Crc) Patients and Healthy People, Biologia (2019)
11. Design, Synthesis, and Cytotoxicity Evaluation of Novel Indole-Acylhydrazone Derivatives of 4-Pyridinone As Potential Histone Deacetylase-2 Inhibitors, Research in Pharmaceutical Sciences (2022)
12. Ret Protein Expression in Colorectal Cancer; an Immunohistochemical Assessment, Asian Pacific Journal of Cancer Prevention (2021)
13. Gene Network Analysis of Oxaliplatin-Resistant Colorectal Cancer to Target a Crucial Gene Using Chitosan/Hyaluronic Acid/Protamine Polyplexes Containing Crispr-Cas9, Biochimica et Biophysica Acta - General Subjects (2023)
14. Exploring the Role of Interleukin 11 in Cancer Progression, Patient Survival, and Therapeutic Insights, Molecular Biology Reports (2024)
15. Formononetin and Dihydroartemisinin Act Synergistically to Induce Apoptosis in Human Acute Myeloid Leukemia Cell Lines, Cell Journal (2024)
16. Evaluation of Cd133 Expression Rate in Colon Cancers With Immunohistochemistry Method and Its Relationship With Colon Cancer Prognosis, Immunopathologia Persa (2024)
17. Identification of Genes With High Heterogeneity of Expression As a Predictor of Different Prognosis and Therapeutic Responses in Colorectal Cancer: A Challenge and a Strategy, Cancer Cell International (2022)
18. Gene Expression Profile Analysis of Colon Cancer Grade Ii Into Grade Iii Transition by Using System Biology, Gastroenterology and Hepatology from Bed to Bench (2019)
19. The Effect of Licorice Protein Fractions on Proliferation and Apoptosis of Gastrointestinal Cancer Cell Lines, Nutrition and Cancer (2017)
20. Association Between Colorectal Cancer and the Degree of Itga4 Promoter Methylation in Peripheral Blood Mononuclear Cells, Gene Reports (2022)
21. Expression and Prognostic Significance of Stem Cell Marker Cd133 in Survival Rate of Patients With Colon Cancer, Oncology and Therapy (2022)
22. Analysing Glycolysis-Related Genes Reveals the Prognostic and Diagnostic Relevance of Ier3 and Agrn in Colorectal Cancer, Genes and Genomics (2025)
23. Global, Regional, and National Burden of Colorectal Cancer and Its Risk Factors, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Gastroenterology and Hepatology (2022)